Harth, G., Horwitz, M. A., Tabatadze, D., & Zamecnik, P. C. (2002). Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology. National Academy of Sciences.
Citação norma ChicagoHarth, Günter, Marcus A. Horwitz, David Tabatadze, and Paul C. Zamecnik. Targeting the Mycobacterium Tuberculosis 30/32-kDa Mycolyl Transferase Complex As a Therapeutic Strategy against Tuberculosis: Proof of Principle By Using Antisense Technology. National Academy of Sciences, 2002.
Citação norma MLAHarth, Günter, Marcus A. Horwitz, David Tabatadze, and Paul C. Zamecnik. Targeting the Mycobacterium Tuberculosis 30/32-kDa Mycolyl Transferase Complex As a Therapeutic Strategy against Tuberculosis: Proof of Principle By Using Antisense Technology. National Academy of Sciences, 2002.